The magnitude of the T cell response to a clinically significant dose of influenza virus is regulated by TRAIL

Immunology and Microbiology

• TRAIL 100%
• Influenza Virus 100%
• T Cell 100%
• Influenza A Virus 100%
• Cytotoxic T-Cell 60%
• Infectious Disease 50%
• Infection 50%
• Lung 30%
• Morbidity 30%
• Wild Type Mouse 30%
• Immune Response 20%
• Immunopathology 20%
• Viral Clearance 20%
• Inflammation 10%
• Infectious Agent 10%
• Cytotoxicity 10%
• Perforin 10%
• Influenza A Virus (A/Puerto Rico/8/1934(H1N1)) 10%
• Chemokine 10%
• Granzyme B 10%
• Lymphocyte 10%
• Programmed Cell Death 10%
• Virus Infection 10%

Keyphrases

• Clinically Significant 100%
• Influenza Virus 100%
• T Cell Response 100%
• Virus-specific 45%
• CD8 T Cells 36%
• Lung 27%
• Wild Mice 27%
• CD8+ T Cell Response 18%
• Viral Clearance 18%
• Immunopathology 18%
• Virus-infected Cell 18%
• FasL 9%
• Immune Response 9%
• T Cell Immune Response 9%
• Apoptosis 9%
• Copyright 9%
• Pulmonary Inflammation 9%
• Pulmonary Pathology 9%
• Inflammatory Chemokines 9%
• Primary Infection 9%
• H1N1 Infection 9%
• Pulmonary Infection 9%
• Pathogen Spread 9%
• Chemokine Production 9%
• Granzyme B 9%
• Perforin 9%
• Cytotoxic Activity 9%
• MIP-1b 9%
• Infiltrating Lymphocytes 9%
• Influenza Virus Infection 9%